Stock-Based Compensation (Narrative) (Details)					1 Months Ended	3 Months Ended		6 Months Ended
	Apr. 29, 2024 USD ($) milestone employee	Feb. 24, 2024 USD ($) milestone	Oct. 04, 2022 USD ($) shares	Dec. 01, 2021 USD ($) milestone	Feb. 29, 2024 USD ($) milestone	Jun. 30, 2024 USD ($) milestone $ / shares shares	Jun. 30, 2023 USD ($)	Jun. 30, 2024 USD ($) milestone $ / shares shares	Jun. 30, 2023 USD ($)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period								3 years
Stock-based compensation expense						$ 5,421,000	$ 7,990,000	$ 13,673,000	$ 18,282,000
Unrecognized stock-based compensation expense						$ 26,015,000		$ 26,015,000
Unrecognized stock-based compensation expense, period for recognize								1 year 8 months 12 days
Share-Based Payment Arrangement, Tranche One
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting percentage								33.33%
Share-Based Payment Arrangement, Tranche Two
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting percentage								33.33%
Share-Based Payment Arrangement, Tranche Three
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting percentage								33.33%
Phantom Share Units (PSUs) | Systemic Bio Phantom Unit Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period								4 years
Granted (in shares) | shares						6,000		94,000
Stock-based compensation expense						$ 2,030,000	0	$ 2,097,000	0
Share-based compensation arrangement, increased expense valuation						$ 1,913,000		$ 1,913,000
Basic (in dollars per share) | $ / shares						$ 0.01		$ 0.01
Performance Shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of non-financial milestones | milestone						4		4
Restricted Stock Units (RSUs)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period						3 years		3 years
Granted (in shares) | shares						60,000		60,000
Granted (in dollars per share) | $ / shares						$ 5.75		$ 5.75
Incentive Awards
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense						$ 680,000	397,000	$ 2,274,000	1,055,000
Volumetric Milestones
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation arrangement by share-based payment award, milestone awards recognized							(632,000)		(632,000)
RegMed Milestone
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation arrangement by share-based payment award, milestone awards recognized							1,634,000		1,634,000
Volumetric Biotechnologies, Inc.
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense						$ 0	(632,000)	$ 0	1,634,000
Additional payments	$ 175,000,000	$ 355,000,000		$ 355,000,000	$ 355,000,000
Number of milestones | milestone	7			7		7		7
Milestones terminated | milestone	4	4			4
Remaining milestones | milestone	3	3			3
Business combination, contingent consideration, reduced liability		$ 175,000,000			$ 175,000,000
Number of employees | employee	2
Earnout payment milestone							65,000,000		65,000,000
Aggregate grant date fair value of outstanding and unvested							4,773,000		4,773,000
Volumetric Biotechnologies, Inc. | Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of milestones | milestone					4
Volumetric Biotechnologies, Inc. | Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of milestones | milestone					7
Dp polar GmbH
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense						$ 733,000	$ 277,000	$ 975,000	$ 552,000
Additional payments			$ 2,229,000
Issuance of shares (in shares) | shares			250,000